AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Franconi, F.
Right arrow Articles by Seghieri, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Franconi, F.
Right arrow Articles by Seghieri, G.
Agricola
Right arrow Articles by Franconi, F.
Right arrow Articles by Seghieri, G.

American Journal of Clinical Nutrition, Vol 61, 1115-1119, Copyright © 1995 by The American Society for Clinical Nutrition, Inc


ORIGINAL RESEARCH COMMUNICATIONS

Plasma and platelet taurine are reduced in subjects with insulin- dependent diabetes mellitus: effects of taurine supplementation

F Franconi, F Bennardini, A Mattana, M Miceli, M Ciuti, M Mian, A Gironi, R Anichini and G Seghieri
Institute of Biochemistry, University of Sassari, Italy.

Plasma and platelet taurine concentrations were assayed in 39 patients with insulin-dependent diabetes mellitus (IDDM) and in 34 control subjects matched for age, sex, and both total and protein-derived daily energy intake. Platelet aggregation induced by arachidonic acid in vitro at baseline and after oral taurine supplementation (1.5 g/d) for 90 d was also studied. Plasma and platelet taurine concentrations (mean +/- SEM) were lower in diabetic patients (65.6 +/- 3.1 mumol/L, or 0.66 +/- 0.07 mol/g protein) than in control subjects (93.3 +/- 6.3 mumol/L, or 0.99 +/- 0.16 mol/g protein, P < 0.01). After oral supplementation, both plasma and platelet taurine concentrations increased significantly in the diabetic patients, reaching the mean values of healthy control subjects. The effective dose (mean +/- SEM) of arachidonic acid required for platelets to aggregate was significantly lower in diabetic patients than in control subjects (0.44 +/- 0.07 mmol compared with 0.77 +/- 0.02 mmol, P < 0.001, whereas after taurine supplementation it equaled the mean value for healthy control subjects (0.72 +/- 0.04 mmol). In in vitro experiments, taurine reduced platelet aggregation in diabetic patients in a dose-dependent manner, whereas 10 mmol taurine/L did not modify aggregation in healthy subjects.


This article has been cited by other articles:


Home page
Lab AnimHome page
M Jensen-Waern, M Andersson, R Kruse, B Nilsson, R Larsson, O Korsgren, and B Essen-Gustavsson
Effects of streptozotocin-induced diabetes in domestic pigs with focus on the amino acid metabolism
Lab Anim, July 1, 2009; 43(3): 249 - 254.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
C. M. H. Anderson, A. Howard, J. R. F. Walters, V. Ganapathy, and D. T. Thwaites
Taurine uptake across the human intestinal brush-border membrane is via two transporters: H+-coupled PAT1 (SLC36A1) and Na+- and Cl--dependent TauT (SLC6A6)
J. Physiol., February 15, 2009; 587(4): 731 - 744.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Merheb, R. T. Daher, M. Nasrallah, R. Sabra, F. N. Ziyadeh, and K. Barada
Taurine Intestinal Absorption and Renal Excretion Test in Diabetic Patients: A pilot study
Diabetes Care, October 1, 2007; 30(10): 2652 - 2654.
[Full Text] [PDF]


Home page
Integr Cancer TherHome page
M. F. McCarty and K. I. Block
Toward a Core Nutraceutical Program for Cancer Management
Integr Cancer Ther, June 1, 2006; 5(2): 150 - 171.
[Abstract] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
F. Li, I. G. Obrosova, O. Abatan, D. Tian, D. Larkin, E. L. Stuenkel, and M. J. Stevens
Taurine replacement attenuates hyperalgesia and abnormal calcium signaling in sensory neurons of STZ-D rats
Am J Physiol Endocrinol Metab, January 1, 2005; 288(1): E29 - E36.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
B. Rakotoambinina, L. Marks, A. M. Badran, F. Igliki, F. Thuillier, P. Crenn, B. Messing, and D. Darmaun
Taurine kinetics assessed using [1,2-13C2]taurine in healthy adult humans
Am J Physiol Endocrinol Metab, August 1, 2004; 287(2): E255 - E262.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Bustamante, M. V. T. Lobo, F. J. Alonso, N.-T. A. Mukala, E. Gine, J. M. Solis, J. Tamarit-Rodriguez, and R. Martin Del Rio
An osmotic-sensitive taurine pool is localized in rat pancreatic islet cells containing glucagon and somatostatin
Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1275 - E1285.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. D Militante, J. B Lombardini, and S. W Schaffer
The role of taurine in the pathogenesis of the cardiomyopathy of insulin-dependent diabetes mellitus
Cardiovasc Res, June 1, 2000; 46(3): 393 - 402.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
Q. di Wu, J. H. Wang, F. Fennessy, H. P. Redmond, and D. Bouchier-Hayes
Taurine prevents high-glucose-induced human vascular endothelial cell apoptosis
Am J Physiol Cell Physiol, December 1, 1999; 277(6): C1229 - C1238.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by The American Society for Nutrition